智通财经APP讯，海西新药(02637)发布公告，林慧怡女士(林女士)已辞任本公司联席公司秘书;《香港联合交易所有限公司(联交所)证券上市规则》第3.05条项下所规定的本公司授权代表;根据香港法例第622章《公司条例》第16部项下的本公司授权代表(连同上市规则项下的授权代表称为“授权代表”);及上市规则第19A.13(2)条所规定代本公司在香港接收法律程序文件及通知书的本公司授权人士(法律程序代理人)，自2026年3月6日起生效。张俊环女士(张女士)仍为其中一名联席公司秘书。
刘国贤先生(刘先生)已获委任为联席公司秘书、授权代表及法律程序代理人，自2026年3月6日起生效。
更多港股重磅资讯，下载智通财经app
更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.